SAFEGUARD YOUR PATIENTS BY MINIMIZING THEIR EXPOSURE TO STAFF AND VISITORS.
Our go-anywhere, battery-operated and self-shielded mobile CT scanners facilitate rapid, clinical decision-making and reduce the risk associated with transporting patients to Radiology.
BODYTOM ELITE Clinical Benefits
Rapid scan time, flexible settings and immediate image viewing makes the 32-slice BodyTom Elite a valuable tool to any facility needing versatile real-time mobile imaging for low dose infectious disease screening protocol.
Large 85cm bore (60cm FOV) comfortably accommodates large patients.
With an innovative internal drive system, the BodyTom Elite can easily be transported from room to room through a standard door.
Internal lead shielding and self-shielded wireless workstation compatible with PACS, EMR, planning systems, surgical and robotic navigation systems.
Charge by a 120V/20A or 240V/30A standard outlet or generator.
OMNITOM Clinical Benefits
State-of-the-art, multi-slice CT including CTA/CTP real time data for infectious disease screening at the patient’s bedside.
40cm bore for Pediatric/Adult Head and Neck/Extremity scanning.
360 degree movement designed with a single user in mind.
Scan board and table adapter stored with unit saving set up time.
Easy charging using a standard wall outlet.
Watch Now
INFECTION PREVENTION PROTOCOLS WITH MOBILE CT Watch Judy Samuelman, Clinical Marketing Manager-mCT present the history of NeuroLogica and the profound impact mobile CT has on infectious disease prevention. WATCH NOW >
Articles & Press Releases
CT Slide: On the Move - Mobilizing CT to Fight COVID-19
Read CT Slide: On the Move - Mobilizing CT to Fight COVID-19 by Jeanne-Marie Phillips from Radiology Today, Vol. 21 No. 6 READ THE ARTICLE >
VA Hospitals Deploy BodyTom® Elite Mobile CT for Patient Distancing
The Memphis Veterans Affairs (VA) Medical Center has selected Samsung NeuroLogica BodyTom Elite mobile computed tomography (CT) for dedicated imaging in designated areas that isolate potential patients with infectious disease from its general patient population. READ THE PRESS RELEASE >
